Richardson Miranda Machado

PERCEPÇÕES DE ESTUDANTES DE ENFERMAGEM SOBRE EDUCAÇÃO A DISTÂNCIA

Objetivo: Analizar la percepcion de los estudiantes de Enfermeria de una institucion de educacion superior en el uso de la educacion a distancia. Metodo: Se trata de un estudio con un enfoque cualitativo. Se entrevisto a 12 estudiantes de licenciatura de Enfermeria de una institucion publica de educacion superior. Los datos recogidos fueron organizados y analizados mediante el analisis de contenido. Resultados: Se encontro que los estudiantes de enfermeria ya tienen experiencias variadas en relacion con la educacion a distancia, que permite la busqueda del conocimiento, el desarrollo profesional y la actualizacion. Identificaron facilidades en relacion a la educacion a distancia, tales como la flexibilidad horaria, reduccion de costos, desplazamiento y el estimulo de autoa-prendizaje. Sin embargo, destacaron dificultades relacionadas con cuestiones tecnicas, sobrecarga de actividades y dificultades en el ejercicio de su autonomia. La ausencia de un proceso de capacitacion sistematica para el manejo de las tecnologias en la educacion a distancia fue otro punto planteado por los encuestados. Conclusion: Enfermeria ha encontrado en la educacion a distancia posibilidades de avances en el conocimiento, mejora en la busqueda de informacion y desarrollo de la profesion. Sin embargo, deben ser superarados desafios, como la necesidad de mejorar la tecnologia en si misma, un proceso de formacion sistematica y continua, asi como el desarrollo de la autonomia en los procesos de ensenanza y aprendizaje.

Esquizofrenia refratária: qualidade de vida e fatores associados

Objective To analyze the quality of life of people with refractory schizophrenia using clozapine, and its associated factors. Methods A cross-sectional study, conducted in the extended western region of Minas Gerais, which included patients with refractory schizophrenia using the antipsychotic, clozapine. For the measurement of quality of life, the Quality of Life Scale was used, specific for patients with schizophrenia. Univariate and multivariate analyses were performed. Results A total of 72 patients with a mean age of 42.9 years was part of the study. The overall score of the Quality of Life Scale indicated compromised quality of life, with a greater impairment in the social network domain (median = 2.36). The logistic regression analysis showed factors associated with a better quality of life. Conclusion Low quality of life in patients with refractory schizophrenia was found. Physical activity, family income over three times the minimum wage, and having children were associated with a better quality of life.

Depressão masculina: um estudo sobre as internações na região centro-oeste de Minas Gerais

Objective: to identify socio-demographic and clinical characteristics of the male genre suffering by Depressive Disorder. Method: retrospective and exploratory study conducted at the Clinical St. Benedict Menni, consisting of 399 patients. Results: the predominant features were age 41-50 years with 109 (27.3%); hospitalized by family own with 164 (41.1%) and length of stay exceeding 30 days, with 101 (25,3%). The largest type of liberation of the hospital was classified as medical liberation, with 330 (82.7%). The first hospitalization prevailed, with 350 (87.7%). The main funder of hospitalizations were in the Public Health System, with 321 (80.4%) admissions. Conclusion: the fact that men report less depressive symptoms contributes to the fake idea that Depressive Disorders affect less the male genre. In the last years, the number of admitted men through depression raised. Therefore health of these must receive attention

Prevalencia de polimorfismos en los genes ANKK1, DRD2, DRD3 y síndrome metabólico en la esquizofrenia refractária

Objetivo: estimar a prevalencia dos polimorfismos TaqIA, -141C e rs6280 dos genes ANKK1, DRD2 e DRD3 e avaliar sua associacao com a ocorrencia de sindrome metabolica em pacientes com esquizofrenia refrataria. Metodo: estudo de delineamento transversal, realizado na Regiao Ampliada Oeste de Minas Gerais, que incluiu pacientes com esquizofrenia refrataria em uso do antipsicotico clozapina. Foram coletados dados sociodemograficos, clinicos, antropometricos, bioquimicos e geneticos. Realizou-se analise univariada dos dados. Resultados: participaram 72 pacientes e observou-se a ocorrencia de Sindrome Metabolica em 47,2%, nao sendo encontrada associacao da Sindrome Metabolica com os polimorfismos estudados. Houve diferenca estatisticamente significante com o parâmetro do baixo HDL com genotipo homozigoto para alelo C do polimorfismo -141C do gene DRD2. Conclusao: evidenciou-se prevalencia de SM elevada. O polimorfismo -141C associou-se ao baixo HDL. A analise genetica e a identificacao de alteracoes metabolicas, neste grupo de pacientes, podem nortear o tratamento medicamentoso e propiciar melhor qualidade de vida.ABSTRACT Objective: to estimate the prevalence of TaqIA, -141C and rs6280 polymorphisms of the ANKK1, DRD2 and DRD3 genes and evaluate their association with the occurrence of metabolic syndrome in patients with refractory schizophrenia. Method: cross-sectional study conducted in the Extended Western Region of Minas Gerais, with refractory schizophrenic patients using the antipsychotic clozapine. Sociodemographic, clinical, anthropometric, biochemical and genetic data were collected. Univariate analysis of the data was performed. Results: seventy-two patients participated in the study and the occurrence of Metabolic Syndrome was observed in 47.2% of them. There was no association between Metabolic Syndrome and the studied polymorphisms. There was a statistically significant difference in the low HDL parameter with homozygous genotype for the C allele of the -141C polymorphism of the DRD2 gene. Conclusion: a high prevalence of MS was evidenced. The -141C polymorphism was associated with low HDL. Genetic analysis and identification of metabolic alterations in this group of patients can guide drug treatment and provide a better quality of life.

Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia

Objetivo: estimar a prevalencia dos polimorfismos TaqIA, -141C e rs6280 dos genes ANKK1, DRD2 e DRD3 e avaliar sua associacao com a ocorrencia de sindrome metabolica em pacientes com esquizofrenia refrataria. Metodo: estudo de delineamento transversal, realizado na Regiao Ampliada Oeste de Minas Gerais, que incluiu pacientes com esquizofrenia refrataria em uso do antipsicotico clozapina. Foram coletados dados sociodemograficos, clinicos, antropometricos, bioquimicos e geneticos. Realizou-se analise univariada dos dados. Resultados: participaram 72 pacientes e observou-se a ocorrencia de Sindrome Metabolica em 47,2%, nao sendo encontrada associacao da Sindrome Metabolica com os polimorfismos estudados. Houve diferenca estatisticamente significante com o parâmetro do baixo HDL com genotipo homozigoto para alelo C do polimorfismo -141C do gene DRD2. Conclusao: evidenciou-se prevalencia de SM elevada. O polimorfismo -141C associou-se ao baixo HDL. A analise genetica e a identificacao de alteracoes metabolicas, neste grupo de pacientes, podem nortear o tratamento medicamentoso e propiciar melhor qualidade de vida.ABSTRACT Objective: to estimate the prevalence of TaqIA, -141C and rs6280 polymorphisms of the ANKK1, DRD2 and DRD3 genes and evaluate their association with the occurrence of metabolic syndrome in patients with refractory schizophrenia. Method: cross-sectional study conducted in the Extended Western Region of Minas Gerais, with refractory schizophrenic patients using the antipsychotic clozapine. Sociodemographic, clinical, anthropometric, biochemical and genetic data were collected. Univariate analysis of the data was performed. Results: seventy-two patients participated in the study and the occurrence of Metabolic Syndrome was observed in 47.2% of them. There was no association between Metabolic Syndrome and the studied polymorphisms. There was a statistically significant difference in the low HDL parameter with homozygous genotype for the C allele of the -141C polymorphism of the DRD2 gene. Conclusion: a high prevalence of MS was evidenced. The -141C polymorphism was associated with low HDL. Genetic analysis and identification of metabolic alterations in this group of patients can guide drug treatment and provide a better quality of life.

Prevalência de polimorfismos nos genes ANKK1, DRD2, DRD3 e síndrome metabólica na esquizofrenia refratária

Objetivo: estimar a prevalencia dos polimorfismos TaqIA, -141C e rs6280 dos genes ANKK1, DRD2 e DRD3 e avaliar sua associacao com a ocorrencia de sindrome metabolica em pacientes com esquizofrenia refrataria. Metodo: estudo de delineamento transversal, realizado na Regiao Ampliada Oeste de Minas Gerais, que incluiu pacientes com esquizofrenia refrataria em uso do antipsicotico clozapina. Foram coletados dados sociodemograficos, clinicos, antropometricos, bioquimicos e geneticos. Realizou-se analise univariada dos dados. Resultados: participaram 72 pacientes e observou-se a ocorrencia de Sindrome Metabolica em 47,2%, nao sendo encontrada associacao da Sindrome Metabolica com os polimorfismos estudados. Houve diferenca estatisticamente significante com o parâmetro do baixo HDL com genotipo homozigoto para alelo C do polimorfismo -141C do gene DRD2. Conclusao: evidenciou-se prevalencia de SM elevada. O polimorfismo -141C associou-se ao baixo HDL. A analise genetica e a identificacao de alteracoes metabolicas, neste grupo de pacientes, podem nortear o tratamento medicamentoso e propiciar melhor qualidade de vida.ABSTRACT Objective: to estimate the prevalence of TaqIA, -141C and rs6280 polymorphisms of the ANKK1, DRD2 and DRD3 genes and evaluate their association with the occurrence of metabolic syndrome in patients with refractory schizophrenia. Method: cross-sectional study conducted in the Extended Western Region of Minas Gerais, with refractory schizophrenic patients using the antipsychotic clozapine. Sociodemographic, clinical, anthropometric, biochemical and genetic data were collected. Univariate analysis of the data was performed. Results: seventy-two patients participated in the study and the occurrence of Metabolic Syndrome was observed in 47.2% of them. There was no association between Metabolic Syndrome and the studied polymorphisms. There was a statistically significant difference in the low HDL parameter with homozygous genotype for the C allele of the -141C polymorphism of the DRD2 gene. Conclusion: a high prevalence of MS was evidenced. The -141C polymorphism was associated with low HDL. Genetic analysis and identification of metabolic alterations in this group of patients can guide drug treatment and provide a better quality of life.

PREVALENCIA DE SÍNDROME METABÓLICO EN PACIENTES CON ESQUIZOFRENIA REFRACTARIA

Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.

PREVALÊNCIA DE SÍNDROME METABÓLICA EM PACIENTES COM ESQUIZOFRENIA REFRATÁRIA

Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.

METABOLIC SYNDROME PREVALENCE IN PATIENTS WITH REFRACTORY SCHIZOPHRENIA

Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.Objective: To estimate the prevalence of the metabolic syndrome (MS) and its associated factors in patients with refractory schizophrenia using the antipsychotic clozapine. Method: This is a descriptive cross-sectional study conducted in the extended western region of Minas Gerais (MG), Brazil, in 2015, using a sample of 72 patients. We collected sociodemographic, clinical, anthropometric and biochemical data and conducted descriptive univariate and multivariate analysis. Results: We verified the prevalence of MS in 47.2% of the sample, with a greater predominance among women (58.8%). Patients with MS showed higher change values, especially in relation to blood glucose and triglycerides. The use of four or more medications and the presence of overweight and obesity were associated with MS. In addition, patients with the syndrome had fewer cases of psychiatric hospitalizations than those who did not have it. Conclusion: High and alarming levels of MS prevalence were found in patients with refractory schizophrenia. The presence of overweight and obesity and the use of 4 or more medications may be associated with the development of the MS in this group. These levels could represent an important indicator of cardiovascular risk, which raises the need to develop strategies for primary prevention of metabolic alterations, and highlights the importance of a periodical monitoring of the patient, especially regarding the components of the MS.

Socio-demographic and clinical profile of elderly people with depression and the use of psychoactive drugs

Objective: to know the socio-demographic and clinical profile of elderly patients with depressive disorders and the use of psychoactive drugs. Methods: it is a retrospective epidemiological study that analyzed 218 medical records of elderly patients in a Psychosocial Care Center in a period of 72 months. Results: it was observed that 67.9% of elderly men were predominantly those aged between 60 and 70 years. Alcohol was the most commonly used drug among men and tobacco among women, depression was the most frequent occurrence in both sexes. 53.7% were assisted at a health unit, and the predominant time of treatment was from 31 to 60 days (47.7%). The patients assisted by the family health teams were less frequent (10.5%). Conclusion: the cultural aspects of man’s role in society, easily accessible drugs (alcohol and tobacco) and the lack of information were the main factors related to depression and the use of drug by the elderly.